Skye Bioscience, Inc. ( SKYE) - Key Metrics
SKYE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.27 | -$0.18 | -$0.18 |
| 2026Q1 | $0 | -$0.32 | -$0.22 | -$0.22 |
| 2025Q4 | $0 | -$0.36 | -$0.25 | -$0.25 |
| 2025Q3 | $0 | -$0.32 | -$0.34 | -$0.34 |
| 2025Q2 | $0 | -$0.44 | -$0.27 | -$0.27 |
SKYE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.64 |
| 2026Q1 | 0% | -0.48 |
| 2025Q4 | 0% | -0.52 |
| 2025Q3 | 0% | -3.07 |
| 2025Q2 | 0% | -2.38 |
SKYE
Price: $0.28
52 week price:
Earnings Per Share: -1.08 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 12.7 million